Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans

NCT03135015 is registered in ClinicalTrials.gov with Housey Healthcare ULC as lead sponsor.

NCT NCT03135015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03135015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans
Lead sponsor
Housey Healthcare ULC
Phase
Phase 1
Overall status
Completed
Start date
April 26, 2017
Completion date
June 21, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, diabetes